Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-03-27
2007-03-27
Maier, Leigh C. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S055000, C514S056000, C514S057000, C514S058000, C514S059000, C514S060000, C536S002000, C536S055100, C536S055200, C536S123100, C536S123120
Reexamination Certificate
active
10859577
ABSTRACT:
The present invention relates to polysaccharide conjugates that comprise: a polysaccharide that binds to surface-receptors present on Antigen Presenting Cells, conjugated to one or more compounds having stable carbonyl groups covalently attached, either directly or via a bifunctional linker. The conjugates are useful as immuno-stimulants and adjuvants.
REFERENCES:
patent: 3236792 (1966-02-01), Curtis
patent: 3297604 (1967-01-01), Germino
patent: 4003792 (1977-01-01), Mill et al.
patent: 4063016 (1977-12-01), Austin
patent: 4115305 (1978-09-01), Hornby et al.
patent: 4424346 (1984-01-01), Hall et al.
patent: 4613665 (1986-09-01), Larm
patent: 4663448 (1987-05-01), Chiu et al.
patent: 4675394 (1987-06-01), Solarek et al.
patent: 4693891 (1987-09-01), Collins et al.
patent: 4695624 (1987-09-01), Marburg et al.
patent: 4698387 (1987-10-01), Schmidt et al.
patent: 4703116 (1987-10-01), Solarek et al.
patent: 4731162 (1988-03-01), Solarek et al.
patent: 4739046 (1988-04-01), Di Luzio
patent: 4741804 (1988-05-01), Solarek et al.
patent: 4749800 (1988-06-01), Jobe et al.
patent: 4771127 (1988-09-01), Cryz et al.
patent: 4795745 (1989-01-01), Larm et al.
patent: 4801699 (1989-01-01), Solarek et al.
patent: 4804769 (1989-02-01), Solarek et al.
patent: 4895724 (1990-01-01), Cardinal et al.
patent: 4983748 (1991-01-01), Tsai et al.
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5110909 (1992-05-01), Dellacherie et al.
patent: 5169840 (1992-12-01), Otterlei et al.
patent: 5433955 (1995-07-01), Bredehorst et al.
patent: 5508310 (1996-04-01), Rhodes
patent: 5554386 (1996-09-01), Groman et al.
patent: 5567685 (1996-10-01), Linden et al.
patent: 5591771 (1997-01-01), Markonius
patent: 5607677 (1997-03-01), Jamas et al.
patent: 5624914 (1997-04-01), Patel et al.
patent: 5668193 (1997-09-01), Gouda et al.
patent: 5688931 (1997-11-01), Nogusa et al.
patent: 5747475 (1998-05-01), Nordquist et al.
patent: 5785975 (1998-07-01), Parikh et al.
patent: 5912000 (1999-06-01), Podolski et al.
patent: 5929049 (1999-07-01), Singh et al.
patent: 5989552 (1999-11-01), McKenzie et al.
patent: 6011008 (2000-01-01), Domb et al.
patent: 6573245 (2003-06-01), Marciani
patent: 8202708 (1983-12-01), None
patent: 0 320 942 (1989-06-01), None
patent: 0 326 111 (1989-08-01), None
patent: 0 477 508 (1992-04-01), None
patent: 60-051702 (1985-03-01), None
patent: 06-166635 (1994-06-01), None
patent: WO 96/20012 (1996-07-01), None
patent: WO 97/33612 (1997-09-01), None
patent: WO 99/07744 (1999-02-01), None
Ambrosino, D.M., et al., “Effect of Haemophilus influenzae Polysaccharide Outer Membrane Protein Complex Conjugate Vaccine on Macrophages,”J. Immunol.149:3978-3983, The American Association of Immunologists (1992).
Apostolopoulos, V., et al., “Oxidative/reductive conjugation of mannan to antigen selects for T1or T2immune responses,”Proc. Natl. Acad. Sci. USA92:10128-10132, National Academy of Sciences (1995).
Apostolopoulos, V., et al., “Cell-mediated immune responses to MUC1 fusion protein coupled to mannan,”Vaccine14:930-938, Elsevier Science Ltd. (Jun. 1996).
Azuma, I., “Synthetic immunoadjuvants: application to non-specific host stimulation and potentiation of vaccine immunogenicity,”Vaccine10:1000-1006, Butterworth-Heineman Ltd. (1992).
Barreto-Bergter, E. and Gorin, P.A.J., “Structural Chemistry of Polysaccharides from Fungi and Lichens,”Adv. Carbo. Chem.&Biochem.41:67-103, Academic Press, Inc. (1983).
Berger, L.R. and Reynolds, D.M., “The Chitinase System of a Strain ofStreptomyces Griseus,”Biochim. et Biophys. Acta29:522-534, Elsevier Publishing Company (1958).
Bogwald, J., et al., “Coupling of polysaccharides activated by means of chloroacetaldehyde dimethyl acetyl to amines or proteins by reductive amination,”Carbohydrate Res.148:101-107, Elsevier Sci nce Publishers B.V. (1986).
Bohn, J.A. and BeMiller, J.N., “(1→3)-β-D-Glucans as biological response modifiers: a review of structure-functional activity relationships,”Carbo. Poly.28:3-14, Elsevier Science Ltd. (1995).
Chang, R-C., and Shaw, J-F., “The immobilization of Candida cylindracea lipase on PVC, chitin and agarose,”Bot. Bull. Acad. Sinica(Taiwan) 28:33-42, Taipei Academia Sinica. Institute Of Botany (1987).
Chen, H. and Rhodes, J., “Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential,”J. Mol. Med.74:497-504, Springer-Verlag (Sep. 1996).
Cryz Jr., S.J., et al., “Pseudomonas aeruginosa Immunotype 5 Polysaccharide-Toxin A Conjugate Vaccine,”Infect. Immun.52:161-165, American Society for Microbiology (1986).
Cryz, Jr., S.J., et al., “Pseudomonas aeruginosa Polysaccharide-Tetanus Toxoid Conjugate Vaccine: Safety and Immunogenicity in Humans,”J. Infect. Dis.154:682-688, The University of Chicago (1986).
Cryz, Jr., S.J., et al., “Vaccine Potential of Pseudomonas aeruginosa O-Polysaccharide-Toxin A Conjugates,”Infect. Immun.55:1547-1551, American Society for Microbiology (1987).
Cryz Jr., S.J., et al., “Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine,”Microb. Pathog.6:75-80, Academic Press, Ltd. (1989).
Cui, H., et al., “Cyclodextrin glucotransferase immobilized on konjac glucomannan,”Tiaran Chanwu Yanjiu Yu Kaifa5:48-54, Chengtu Chin Int. Book Trading Corp. (1993).
Dalsgaard, K., “A Study of the Isolation and Characterization of the Saponin Quil A. Evaluation of Its Adjuvant Activity, With a Special Reference to the Application in the Vaccination of Cattle Against Foot-and-Mouth Disease,”Acta Vet. Scand. Suppl.69, 19:1-40, Danske Dyrlaegeforenging (1978).
Dellacherie, E., and Bonneaux, F., “A new approach to aldehydic dextrans,”Polym. Bull.31:145-149, Springer-Verlag (1993).
Erlanger, B.F., et al., “Steroid-Protein Conjugates. I. Preparation and Characterization of Conjugates of Bovine Serum Albumin with Testosterone and With Cortisone,”J. Biol. Chem.228:713-727, The American Society of Biological Chemists, Inc. (1957).
Good, A.H., et al., “Identification of Carbohydrate Structures That Bind Human Antiporcine Antibodies: Implications for Discordant Xenografting in Humans,”Transplant. Proc.24:559-562, Elsevier Science, Inc. (1992).
Hahn, M.G. and Albersheim, P., “Host-Pathogen Interactions. XIV. Isolation and Partial Characterization of an Elicitor from Yeast Extract,”Plant Physiol.62:107-111, American Society for Plant Physiologists (1978).
Inman, J.K., “Thymus-Independent Antigens: The Preparation of Covalent, Hapten-Ficoll Conjugates,”J. Immunol.114:704-709, The Williams & Wilkins Co. (1975).
Janusz, M.J., et al., “Isolation of Soluble Yeast β-Glucans that Inhibit Human Monocyte Phagocytosis Mediated By β-Glucan Receptors,”J. Immunol.137:3270-3276, The American Association of Immunologists (1986).
Jiang, W., et al., “The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing,”Nature375:151-155, Macmillan Publishers, Ltd. (1995).
Jing, S-B., et al., “Water absorption of chitosan crosslinked by formaldehyde,”Kichin Kitosan Kenkyu1:106-107, Shibayama-machi, Chiba (1995).
Kobayashi, M., and Ichishima, E., Application of periodate oxidized glucans to biochemical reactions,J. Carbohydrate Chem.10:635-644, Marcel Dekker, Inc. (1991).
Kolar, C., et al., “Preparation and Use of Synthetic Blood Group Specific Immunoadsorbents,”Behring Inst. Mitt.82:94-103, Die Medizinische Verlagsgesellschaft mbH (1988).
Kumar, T.S., and Rao, K.P., “Biodegradable chitosan microspheres: a potential carrier for antigens,”Macromolecules—New Front. Proc. IUPAC Int. Symp. Adv. Polm. Sci. Tech.2:657-661, Allied Publ. Ltd. (1998).
Lagergard, T., et al., Synthesis and Immunological Properties of Conjugates Composed of Group B Strepto
Adjuvantys, Inc.
Maier Leigh C.
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Imine-forming polysaccharide adjuvants and immunostimulants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imine-forming polysaccharide adjuvants and immunostimulants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imine-forming polysaccharide adjuvants and immunostimulants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3767412